We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

ASH 2011: Dr. Lonial - A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Sagar Lonial, MD
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles